Evaluating the Impact of Video Discharge Instructions for Mohs Surgery Post-Operative Care
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02970435 |
Recruitment Status :
Terminated
(Slow accrual)
First Posted : November 22, 2016
Last Update Posted : January 25, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Linear Closure Surgery | Behavioral: Video Discharge Instructions Behavioral: Telecommunication Reminders Behavioral: Standard of Care | Not Applicable |
The Primary Objective of this study is to determine if video discharge instructions, when added to standard of care written and verbal instructions, lead to a decrease in unnecessary phone calls from patients in a Mohs dermatology clinic.
The Secondary Objectives of this study are to determine if video discharge instructions, when added to standard of care written and verbal instructions, help to improve patients' satisfaction with education materials provided by the clinic, improve patients' knowledge of post-operative management, improve patients' confidence in taking care of their suture site post-operatively, and reduce post-operative anxiety about their suture site.
This study will be a randomized controlled trial in which the impact of video discharge instructions on patient calls, anxiety, and confidence will be evaluated. Patients will be randomized using a permuted block model generated through SAS.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 14 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Evaluating the Impact of Video Discharge Instructions for Mohs Surgery Post-Operative Care |
Actual Study Start Date : | July 12, 2017 |
Actual Primary Completion Date : | May 1, 2018 |
Actual Study Completion Date : | June 21, 2019 |

Arm | Intervention/treatment |
---|---|
Experimental: Video Discharge Instructions
These videos contain the same instructions that a patient receives via the standard-of-care verbal and written discharge instructions. These instructions will be delivered by the same nursing and medical staff that also regularly provides verbal and written discharge instructions to patients. There will be no difference in the content between the standard-of-care verbal and written instructions and the video discharge instructions. Patients in this group will receive telecommunication reminders on how to access discharge videos.
|
Behavioral: Video Discharge Instructions
The video discharge instructions, will be provided to the patient at the time of surgical procedure. Behavioral: Telecommunication Reminders Telecommunication reminders including text messages, email, or phone calls to remind participants how to access the video discharge instruction up to three times before follow-up Behavioral: Standard of Care Standard of Care: verbal and written discharge instructions for patients after surgery |
Active Comparator: Verbal and Written Discharge Instructions
Nursing and medical staff will provide verbal and written discharge instructions as is standard of care post surgery
|
Behavioral: Standard of Care
Standard of Care: verbal and written discharge instructions for patients after surgery |
- Ratio of patients in the intervention group who call the clinic compared to percentage of patients in the control group who call the clinic [ Time Frame: Up to 8 weeks after discharge ]Researchers will record when each participant calls the clinic. The number of people who call in the intervention group will be compared to the number of people who call in the control group. This will give an efficacy measure of the video discharge instructions
- Difference in knowledge of discharge instructions in intervention group versus control group [ Time Frame: Up to 8 weeks after discharge ]Answers to survey questions investigating knowledge of discharge instruction will be compared between the control and intervention groups.
- Difference in confidence in intervention group versus control group [ Time Frame: Up to 8 weeks after discharge ]A survey investigating confidence about Mohs surgery post-operative care will be used in this study. This survey will be quantified using the Likert scale.
- Difference in satisfaction in intervention group versus control group [ Time Frame: Up to 8 weeks after discharge ]A survey investigating patient satisfaction about Mohs surgery post-operative care will be used in this study. This survey will be quantified using the Likert scale.
- Difference in self reported anxiety levels in intervention group versus control group [ Time Frame: Up to 8 weeks after discharge ]A survey investigating anxiety about Mohs surgery post-operative care will be used in this study. This survey will be quantified using the Likert scale.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients who underwent a linear closure on the face at UH Mohs clinic
- Fluent English speakers
Exclusion Criteria:
● Non-fluent English speakers

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02970435
United States, Ohio | |
University Hospitals at Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center | |
Cleveland, Ohio, United States, 44106-5065 |
Principal Investigator: | Jeremy Bordeaux, MD | University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center |
Responsible Party: | Case Comprehensive Cancer Center |
ClinicalTrials.gov Identifier: | NCT02970435 |
Other Study ID Numbers: |
CASE1616 |
First Posted: | November 22, 2016 Key Record Dates |
Last Update Posted: | January 25, 2021 |
Last Verified: | January 2021 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
surgery video discharge instructions |